: EyePoint Pharmaceuticals’ stock soars 212% after company announces positive data for macular degeneration treatment
EyePoint’s stock is on track for its biggest ever one-day percentage gain in heavy volume.
The U.S. dollar has been sliding in the run-up to a widely expected interest-rate cut from the Federal Reserve on...
These retailers have been increasing same-store sales while improving their profit margins
Micron’s stock slumped Monday, just as a longer-term bearish chart pattern appeared for the first time in more than two...
Intel says a new $3 billion government deal reflects the “continued progress” of its foundry business.
Falling mortgage rates could ease the ‘lock-in effect’ that’s put a chill on the housing market.
While Moody’s Ratings placed the credit on review for a possible downgrade Friday on fears the strike will put more...